Research Grade Stem Cells
Relying on its internationally advanced production processes, rigorous quality management system, and extensive experience in IND submissions, Jiuzhitang Maker has established a CQDMO (Contract Quality, Development & Manufacturing Organization) service platform specializing in stem cells and regenerative medicine. This platform provides hospitals, pharmaceutical companies, and research institutions with end-to-end solutions—from preclinical studies all the way through commercial-scale manufacturing—including services such as stem cell bank establishment, process development and optimization, quality control and quality research, regulatory filing and registration support, as well as comprehensive consulting services. As a result, clients can more efficiently advance their drug development projects and accelerate their products' journey to market.
Product Advantages
We don’t just provide “simple supply”—we offer end-to-end support, from the cellular source all the way to research assistance, delivering solutions that meet pharmaceutical-grade standards and helping researchers overcome common challenges in stem cell procurement.
Inter-batch zero drift, with highly reproducible experiments
• Our research-grade human mesenchymal stem cells are sourced from carefully screened healthy donors for each batch, with全程 closed-loop quality control throughout the entire production process.
• Key markers such as CD73, CD90, and CD105 are flow-cytometrically characterized before shipment, with minimal batch-to-batch variation;
• This means: Once the research team receives the cells, they can immediately finalize their experimental plan—no need for repeated troubleshooting due to issues like "sudden loss of cell function" or "systematic data drift." This approach completely eliminates the passive waste of reagents, consumables, and valuable time.
Cellular instability = a triple black hole of time, funding, and publications.
Address "cell stability" upfront.
It’s like buying the most cost-effective and comprehensive insurance for the entire project.
Species are homologous—making experimental data even more meaningful.
• Numerous studies have shown that mouse-derived cells differ significantly from human cells in aspects such as receptor-ligand profiles, metabolic enzyme systems, and the immune microenvironment, leading to insufficient confidence when translating experimental findings into clinical applications. As a result, key validations typically require the use of human-derived cells.
• In recent years, the latest review trends in top journals such as Nature and Cell have also echoed this shift: For studies claiming "clinical relevance," editors and reviewers increasingly prioritize and encourage the inclusion of human-derived cell data to enhance the translatability and credibility of the findings.
Using human-derived stem cells effectively resets the biggest variable— "species differences"—to zero, enabling more authentic experiments, stronger data, higher-quality publications, and faster translation into real-world applications.
Ready-to-use raw cell material—your reliable assistant for exosome extraction
• The research team working on the exosome project often finds itself in dire straits. "Juggling cell management on one hand while fine-tuning the extraction process on the other," their manpower gets relentlessly tied up at the cellular stage, leaving them only able to scratch the surface when it comes to truly optimizing and refining the core extraction techniques.
• Ready-to-use raw cells streamline the process down to just two steps: "receiving" and "extraction." Built on batch-stable cell lines, this approach seamlessly integrates with the research team’s extraction protocols, reducing the experimental cycle by at least 50%. At the same time, it eliminates the risk of total failure caused by cell contamination—guaranteed.
• The research team can dedicate all released personnel to deeply exploring process parameters, ensuring that yield, purity, and functional validation are thoroughly addressed in one go—resulting in more robust data and making it easier to translate findings into impactful publications and patents.
Outsource "cell culture" to us, and you can focus entirely on "exosome science"—eliminating time, costs, and risks all at once, while your experiments hit the fast-forward button.
Our Services
Statement:This product is intended solely for scientific research purposes and must not be used for clinical treatment or any other applications.
Jiuzhitang Maker is a stem-cell pharmaceutical company that exclusively provides human-derived mesenchymal stem cells, completely eliminating the risk of cross-contamination.
We provide a standardized SOP for human-derived MSC culture, covering everything from recovery and seeding to passaging, harvesting, and cryopreservation—ready to be directly filed in your lab’s SOP folder.
Related Business
Jiuzhitang Maker offers three specifications of its Stempanacel® product, with cell counts of 1 million, 15 million, and 50 million cells, respectively. Customized cell volumes tailored to specific user needs are also available upon request.
Learn more
Jiuzhitang Maker’s human neural stem cell injection is a clinical-grade allogeneic neural stem cell product, manufactured under GMP-compliant conditions according to pharmaceutical production standards, on a proprietary cell preparation platform. It boasts a purity level exceeding 99% and is free from exogenous pathogenic microorganisms such as HIV, HBV, HCV, mycoplasma, bacteria, and fungi. The product meets the stringent quality criteria set forth by both the U.S. FDA and China’s NMPA for clinical trials.
Learn more
Jiuzhitang Maker's cytokine lyophilized powder is derived from clinical-grade cells and meticulously prepared on a large-scale production platform adhering to GMP standards—ensuring it meets pharmaceutical-grade quality. This results in enhanced potency and superior safety. With its versatile applications spanning aesthetic repair, cosmetic enhancement, and even innovative cosmetic ingredients, the product holds immense commercial potential, positioning itself as a key driver for groundbreaking advancements in cell-based cosmetic raw materials and applications.
Learn more
Jiuzhitang Maker's exosomes are derived from clinical-grade stem cells and are rigorously prepared on a large-scale production platform adhering to GMP standards—ensuring they meet pharmaceutical-grade quality. As a result, these exosomes exhibit enhanced activity and superior safety profiles. With their versatile applications spanning drug research and development, regenerative aesthetics, and innovative cosmetic ingredients, exosomes hold immense commercial potential and are poised to drive new advancements in the field of stem cell-based cosmetic raw materials and applications.
Learn more
The Jiuzhitang Maker R&D and Production Platform offers customized stem cell-related services—ranging from pharmaceutical development to commercial-scale manufacturing—for hospitals, research institutions, and emerging companies. This platform effectively helps clients streamline project timelines, reduce costs, and accelerate the regulatory approval and commercialization of innovative stem cell-based drug products.
Learn more
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy